These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25073536)

  • 21. Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit.
    Gunay E; Kaya S; Baysal B; Yuksel E; Arac E
    Ren Fail; 2020 Nov; 42(1):704-709. PubMed ID: 32703065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction.
    Turkoglu M; Dizbay M; Ciftçi A; Aksakal FN; Aygencel G
    Int J Antimicrob Agents; 2012 Feb; 39(2):142-5. PubMed ID: 22115538
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No increased acute kidney injury rate through giving an intravenous colistin loading dose in pediatric patients.
    Wacharachaisurapol N; Kawichai S; Chanakul A; Puthanakit T
    Int J Infect Dis; 2021 May; 106():91-97. PubMed ID: 33771669
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?
    Heybeli C; Canaslan K; Oktan MA; Yıldız S; Arda HÜ; Çavdar C; Çelik A; Gökmen N; Cömert B
    J Chemother; 2021 Apr; 33(2):85-94. PubMed ID: 32500843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
    Horcajada JP; Sorlí L; Luque S; Benito N; Segura C; Campillo N; Montero M; Esteve E; Mirelis B; Pomar V; Cuquet J; Martí C; Garro P; Grau S
    Int J Antimicrob Agents; 2016 Dec; 48(6):725-727. PubMed ID: 28128096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of nonconfounded post-computed tomography acute kidney injury in hospitalized patients with stable renal function receiving intravenous iodinated contrast material.
    Moore A; Dickerson E; Dillman JR; Vummidi D; Kershaw DB; Khalatbari S; Davenport MS
    Curr Probl Diagn Radiol; 2014; 43(5):237-41. PubMed ID: 24909428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute Kidney Injury Related to Intravenous Colistin Use in Lebanese Hospitalized Patients: Incidence and Associated Factors.
    Khalifeh M; El-Lakany A; Soubra L
    Curr Drug Saf; 2022; 17(2):152-157. PubMed ID: 34323193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk Factors for Colistin-Associated Acute Kidney Injury: A Multicenter Study from Turkey.
    Gul S; Kuscu F; Aydemir H; Ozturk DB; Deveci O; Duygu F; Kacmaz B; Yaman F; Aslan E
    Jpn J Infect Dis; 2016; 69(2):109-12. PubMed ID: 26166495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toxicity after prolonged (more than four weeks) administration of intravenous colistin.
    Falagas ME; Rizos M; Bliziotis IA; Rellos K; Kasiakou SK; Michalopoulos A
    BMC Infect Dis; 2005 Jan; 5():1. PubMed ID: 15642116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attributable Risk and Time Course of Colistin-Associated Acute Kidney Injury.
    Miano TA; Lautenbach E; Wilson FP; Guo W; Borovskiy Y; Hennessy S
    Clin J Am Soc Nephrol; 2018 Apr; 13(4):542-550. PubMed ID: 29545383
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the risk of nephrotoxicity in patients receiving colistimethate sodium: a multicentre, retrospective, cohort study.
    Phe K; Shields RK; Tverdek FP; Aitken SL; Guervil DJ; Lam WM; Musgrove RJ; Luce AM; Tam VH
    J Antimicrob Chemother; 2016 Dec; 71(12):3585-3587. PubMed ID: 27543655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease after acute kidney injury associated with intravenous colistin use in survivors of severe infections: A comparative cohort study.
    Meraz-Muñoz A; Gomez-Ruiz I; Correa-Rotter R; Ramirez-Sandoval JC
    J Crit Care; 2018 Apr; 44():244-248. PubMed ID: 29175613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emergent renal dysfunction with colistin pharmacotherapy.
    Collins JM; Haynes K; Gallagher JC
    Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia.
    Elefritz JL; Bauer KA; Jones C; Mangino JE; Porter K; Murphy CV
    J Intensive Care Med; 2017 Sep; 32(8):487-493. PubMed ID: 27139010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Colistin-associated nephrotoxicity among patients in intensive care units (ICU) of hospitals in Selangor.
    Rashizal Sazli MR; Syed Mohamed AF; Wan Mazuan WM; Ling SM; Mahmud A; Amin Nordin S
    Med J Malaysia; 2017 Apr; 72(2):100-105. PubMed ID: 28473672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining the incidence and risk factors of colistin-induced acute kidney injury by KDIGO criteria.
    Shields RK; Anand R; Clarke LG; Paronish JA; Weirich M; Perone H; Kieserman J; Freedy H; Andrzejewski C; Bonilla H
    PLoS One; 2017; 12(3):e0173286. PubMed ID: 28267779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephrotoxicity caused by colistin use in ICU: a single centre experience.
    Kilic I; Ayar Y; Ceylan İ; Kaya PK; Caliskan G
    BMC Nephrol; 2023 Oct; 24(1):302. PubMed ID: 37833622
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors of colistin safety according to administration routes: Intravenous and aerosolized colistin.
    Min KL; Son ES; Kim JS; Kim SH; Jung SM; Chang MJ
    PLoS One; 2018; 13(11):e0207588. PubMed ID: 30462703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and predictors of acute kidney injury associated with intravenous polymyxin B therapy.
    Kubin CJ; Ellman TM; Phadke V; Haynes LJ; Calfee DP; Yin MT
    J Infect; 2012 Jul; 65(1):80-7. PubMed ID: 22326553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.